Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
EORTC Melanoma Group
- Utrecht University
- Antoni Van Leeuwenhoek Ziekenhuis
- University of Sydney
- Princess Alexandra Hospital Brisbane
- Hospices Civils de Lyon
- Alfred Hospital
- N N Blokhin Cancer Research Center
- Fiona Stanley Hospital
- Melanoma Institute Australia
- Peter Maccallum Cancer Centre
- Royal Marsden NHS Foundation Trust
- University of Barcelona
- Istituto Nazionale Dei Tumori Napoli
- Center of Oncology
- University of Duisburg-Essen
- Radboud University Nijmegen
- Washington University in St. Louis
- Azienda Ospedaliera Universitaria Senese
- University of Amsterdam
- Aix-Marseille University
- Hannover Medical School
- University of Montreal
- Central Manchester NHS Foundation Trust
- Merck Sharp and Dohme
- University of Brussels
- Université Paris-Saclay
372
Link opens in a new tab
Citations
(Scopus)